A comprehensive view of Celltrion Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Celltrion submits BLA for CT-P39, a biosimilar version of Xolair, to US FDA for treatment of multiple conditions including asthma and food allergies; submission backed by data demonstrating comparable efficacy and safety
Published: March 11, 2024 by PharmaShots

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count